Global Rheumatology Therapeutics Market (By Drug Types- Disease Modifying Anti-Rheumatic Drugs, Corticosteroids, Non-Steroidal Anti-Inflammatory Drugs, Immunosuppressant Drugs, and Biologics. By Disease Types- Rheumatoid Arthritis, Gout, Osteoarthritis, Juvenile Idiopathic Arthritis, Scleroderma, Sjogrens Syndrome, and others. By Method of Administration- Topical, Oral, and Parenteral Administration. By Distribution Channel- Hospital, Online, Retail, and others.) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 - 2025

Global Rheumatology Therapeutics Market (By Drug Types- Disease Modifying Anti-Rheumatic Drugs, Corticosteroids, Non-Steroidal Anti-Inflammatory Drugs, Immunosuppressant Drugs, and Biologics. By Disease Types- Rheumatoid Arthritis, Gout, Osteoarthritis, Juvenile Idiopathic Arthritis, Scleroderma, Sjogrens Syndrome, and others. By Method of Administration- Topical, Oral, and Parenteral Administration. By Distribution Channel- Hospital, Online, Retail, and others.) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 - 2025


  • Products Id :- HC 125
  • |
  • Pages: 150
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

The report covers the analysis and forecast of the rheumatology therapeutics market on global as well as regional level. The study provides historic data of 2016 along with the forecast for the period between 2017 and 2025 based on revenue (USD Mn).

The study provides a detailed view of the rheumatology therapeutics market, by segmenting it based on by drug types, by disease types, by method of administration, by distribution channel, and regional demand. The rise in geriatric population propels the growth of the rheumatology therapeutics market. Growing awareness about the nature of rheumatology therapy is another prime factor driving the market demand. Additionally, swift acceptance of new drugs for treatment of different types of rheumatic diseases fuels the demand of this market.

Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Middle East and Africa and Latin America. The segmentation also includes by drug types, by disease types, by method of administration, by distribution channel in all regions. These include different business strategies adopted by the leading players and their recent developments.

A comprehensive analysis of the market dynamics that is inclusive of market drivers, restraints, and opportunities is part of the report. Additionally, the report includes potential opportunities in the Rheumatology therapeutics market at the global and regional levels. Market dynamics are the factors which impact the market growth, so their analysis helps understand the ongoing trends of the global market. Therefore, the report provides the forecast of the global market for the period from 2017 to 2025, along with offering an inclusive study of the rheumatology therapeutics market.

The report provides the size of the Rheumatology therapeutics market in 2017 and the forecast for the next eight years up to 2025. The size of the global rheumatology therapeutics market is provided in terms of revenue. Market revenue is defined in USD Mn. The market dynamics prevalent in North America, Europe, Asia Pacific, Middle East and Africa and Latin America has been considered in estimating the growth of the global market.

Market estimates for this study have been based on revenue being derived through regional pricing trends. The Rheumatology therapeutics market has been analyzed based on expected demand. Bottom-up approach is done to estimate the global revenue of the rheumatology therapeutics market, split into regions. Based on drug types, disease types, method of administration, and by distribution channel the individual revenues from all the regions is summed up to achieve the global revenue for rheumatology therapeutics. Companies were considered for the market share analysis, based on their innovation and application and revenue generation. In the absence of specific data related to the sales of rheumatology therapeutics several privately held companies, calculated assumptions have been made in view of the company's penetration and regional presence.

The report covers a detailed competitive outlook that includes the market share and company profiles of key players operating in the global market. Key players profiled in the report include Sanofi A.G., Takeda Pharmaceutical, AbbVie Inc., Pfizer Inc., Regeneron, Amgen Inc., and few others.

The global rheumatology therapeutics market has been segmented into:

Global Rheumatology Therapeutics Market: By Drug Types

Disease Modifying Anti-Rheumatic Drugs

Corticosteroids

Non-Steroidal Anti-Inflammatory Drugs

Immunosuppressant Drugs

Biologics

Global Rheumatology Therapeutics Market: By Disease Types

Rheumatoid Arthritis

Gout

Osteoarthritis

Juvenile Idiopathic Arthritis

Scleroderma

Sjogren's Syndrome

Others

Global Rheumatology Therapeutics Market: By Method of Administration

Topical

Oral

Parenteral

Global Rheumatology Therapeutics Market: By Distribution Channel

Hospital

Online

Retail

Others

Global Rheumatology Therapeutics Market: By Geography

North America

o U.S.

o Canada

o Mexico

Europe

o U.K.

o France

o Germany

o Italy

o Rest of Europe

Asia Pacific

o India

o China

o Japan

o Rest of Asia Pacific

Middle East and Africa

o South Africa

o Rest of Middle East and Africa

Latin America

o Brazil

o Rest of Latin America



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 INTRODUCTION

1.1 MARKET SEGMENTATION

2 RESEARCH METHODOLOGY

2.1 ECOSYSTEM OF RHEUMATOLOGY THERAPEUTICS MARKET

2.2 TOP-DOWN APPROACH

2.3 BOTTOM-UP APPROACH

2.4 ASSUMPTIONS

3 EXECUTIVE SUMMARY

3.1 GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET SNAPSHOT

3.2 GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET REVENUE, 2017- 2025(USD MN)

4 MARKET OVERVIEW

4.1 INTRODUCTION

4.2 KEY TRENDS ANALYSIS

4.3 PRODUCT DEVELOPMENT AND DIVERSIFICATION ANALYSIS

4.4 PORTERS FIVE FORCE ANALYSIS

4.5 VALUE CHAIN ANALYSIS

4.6 COMPETITIVE LANDSCAPE

4.7 COMPANY MARKET SHARE ANALYSIS

4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS

5 GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET, BY DRUG TYPES

5.1 OVERVIEW

5.2 DISEASE MODIFYING ANTI-RHEUMATIC DRUGS

5.3 CORTICOSTEROIDS

5.4 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS

5.5 IMMUNOSUPPRESSANT DRUGS

5.6 BIOLOGICS

6 GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET, BY DISEASE TYPE

6.1 OVERVIEW

6.2 RHEUMATOID ARTHRITIS

6.3 GOUT

6.4 OSTEOARTHRITIS

6.5 JUVENILE IDIOPATHIC ARTHRITIS

6.6 SCLERODERMA

6.7 SJOGREN'S SYNDROME

6.8 OTHERS

7 GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET, BY METHOD OF ADMINISTRATION

7.1 OVERVIEW

7.2 TOPICAL

7.3 ORAL

7.4 PARENTERAL

8 GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL

8.1 HOSPITAL

8.2 ONLINE

8.3 RETAIL

8.4 OTHERS

9 GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET, BY GEOGRAPHY

9.1 NORTH AMERICA

9.1.1 MARKET DYNAMICS

9.1.1.1 DRIVERS

9.1.1.2 RESTRAINS

9.1.1.3 OPPORTUNITY

9.1.2 U.S.

9.1.3 CANADA

9.1.4 MEXICO

9.2 EUROPE

9.2.1 MARKET DYNAMICS

9.2.1.1 DRIVERS

9.2.1.2 RESTRAINS

9.2.1.3 OPPORTUNITY

9.2.2 U.K.

9.2.3 FRANCE

9.2.4 GERMANY

9.2.5 SPAIN

9.2.6 REST OF EUROPE

9.3 ASIA PACIFIC

9.3.1 MARKET DYNAMICS

9.3.1.1 DRIVERS

9.3.1.2 RESTRAINS

9.3.1.3 OPPORTUNITY

9.3.2 INDIA

9.3.3 CHINA

9.3.4 JAPAN

9.3.5 REST OF ASIA PACIFIC

9.4 MIDDLE EAST AND AFRICA

9.4.1 MARKET DYNAMICS

9.4.1.1 DRIVERS

9.4.1.2 RESTRAINS

9.4.1.3 OPPORTUNITY

9.4.2 SOUTH AFRICA

9.4.3 REST OF MIDDLE EAST AND AFRICA

9.5 LATIN AMERICA

9.5.1 MARKET DYNAMICS

9.5.1.1 DRIVERS

9.5.1.2 RESTRAINS

9.5.1.3 OPPORTUNITY

9.5.2 BRAZIL

9.5.3 REST OF LATIN AMERICA

10 GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET, BY COMPANY

10.1 INTRODUCTION

10.2 SANOFI S.A.

10.2.1 BUSINESS OVERVIEW

10.2.2 PRODUCTS & SERVICES

10.2.3 KEY STRATEGY

10.2.4 RECENT DEVELOPMENTS

10.2.5 SWOT ANALYSIS

10.3 TAKEDA PHARMACEUTICAL

10.3.1 BUSINESS OVERVIEW

10.3.2 PRODUCTS & SERVICES

10.3.3 KEY STRATEGY

10.3.4 RECENT DEVELOPMENTS

10.3.5 SWOT ANALYSIS

10.4 ABBVIE INC.

10.4.1 BUSINESS OVERVIEW

10.4.2 PRODUCTS & SERVICES

10.4.3 KEY STRATEGY

10.4.4 RECENT DEVELOPMENTS

10.4.5 SWOT ANALYSIS

10.5 REGENERON PHARMACEUTICALS INC.

10.5.1 BUSINESS OVERVIEW

10.5.2 PRODUCTS & SERVICES

10.5.3 KEY STRATEGY

10.5.4 RECENT DEVELOPMENTS

10.5.5 SWOT ANALYSIS

10.6 NOVARTIS AG

10.6.1 BUSINESS OVERVIEW

10.6.2 PRODUCTS & SERVICES

10.6.3 KEY STRATEGY

10.6.4 RECENT DEVELOPMENTS

10.6.5 SWOT ANALYSIS

10.7 AMGEN INC.

10.7.1 BUSINESS OVERVIEW

10.7.2 PRODUCTS & SERVICES

10.7.3 KEY STRATEGY

10.7.4 RECENT DEVELOPMENTS

10.7.5 SWOT ANALYSIS

10.8 JANSSEN BIOTECH INC.

10.8.1 BUSINESS OVERVIEW

10.8.2 PRODUCTS & SERVICES

10.8.3 KEY STRATEGY

10.8.4 RECENT DEVELOPMENTS

10.8.5 SWOT ANALYSIS

10.9 PFIZER INC.

10.9.1 BUSINESS OVERVIEW

10.9.2 PRODUCTS & SERVICES

10.9.3 KEY STRATEGY

10.9.4 RECENT DEVELOPMENTS

10.9.5 SWOT ANALYSIS

10.10 BRISTOL-MYERS SQUIBB COMPANY

10.10.1 BUSINESS OVERVIEW

10.10.2 PRODUCTS & SERVICES

10.10.3 KEY STRATEGY

10.10.4 RECENT DEVELOPMENTS

10.10.5 SWOT ANALYSIS

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license
Single User License
USD 4795 INR 330376
Site License
USD 6795 INR 468176
Corporate User License
USD 7795 INR 537076

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com